Hyper cholestrolemy treatment
Phase 3
- Conditions
- hypercholesterolaemia.Pure hypercholesterolemia
- Registration Number
- IRCT201011015068N1
- Lead Sponsor
- Tehran, Research Institute for Islamic and Complementary Medicine, Tehran university of Medical Sci
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Inclusion critries:
194 < ch<348 or 200Exclusion critries:History of early cardio vascular evevnt, At the admission use any of these drugs:(Cortico Steroid, Androgenic, Ocp, Phenytoin or Lipid reduction drugs), pregnancy, lactating, alcohlic, Drug abuse, History of liver diseaese ,History of renal disease, History of alergy to herbal drugs, refusal to continue the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum cholesterol level. Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: bio chemistry- laboratory.;Serum low density lipoprotein level. Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: biochemistry- laboratory.
- Secondary Outcome Measures
Name Time Method